Consolidated Planning Corp cut its stake in shares of iShares S&P 500 ETF (NYSEARCA:IVV – Get Rating) by 19.1% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 610 shares of the company’s stock after selling 144 shares during the period. Consolidated Planning Corp’s holdings in iShares S&P 500 ETF were worth $219,000 as of its most recent SEC filing.
Several other institutional investors also recently modified their holdings of IVV. Founders Capital Management acquired a new position in shares of iShares S&P 500 ETF during the second quarter worth $32,000. Sterling Investment Advisors Ltd. acquired a new position in shares of iShares S&P 500 ETF during the second quarter worth $38,000. Apeiron RIA LLC increased its holdings in shares of iShares S&P 500 ETF by 598.6% during the second quarter. Apeiron RIA LLC now owns 10,822 shares of the company’s stock worth $49,000 after buying an additional 9,273 shares in the last quarter. New Millennium Group LLC acquired a new position in shares of iShares S&P 500 ETF during the second quarter worth $53,000. Finally, Accel Wealth Management increased its holdings in shares of iShares S&P 500 ETF by 37.4% during the third quarter. Accel Wealth Management now owns 290 shares of the company’s stock worth $110,000 after buying an additional 79 shares in the last quarter.
iShares S&P 500 ETF Trading Down 1.0 %
Shares of NYSEARCA:IVV opened at $398.02 on Wednesday. The company has a fifty day moving average of $394.13 and a 200-day moving average of $392.99. iShares S&P 500 ETF has a 52-week low of $349.53 and a 52-week high of $464.05.
iShares S&P 500 ETF Profile
iShares Core S&P 500 ETF (the Fund) is an exchange-traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Standard & Poor’s 500 Index (the Index). The Index measures the performance of the large-capitalization sector of the United States equity market.
Featured Stories
- Get a free copy of the StockNews.com research report on iShares S&P 500 ETF (IVV)
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab’s First U.S. Launch Send Stock Into Stratosphere?
- When Will Crane Holdings Take Flight?
Want to see what other hedge funds are holding IVV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares S&P 500 ETF (NYSEARCA:IVV – Get Rating).
Receive News & Ratings for iShares S&P 500 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares S&P 500 ETF and related companies with MarketBeat.com's FREE daily email newsletter.